Literature DB >> 25557267

Combination of p16(INK4a) /Ki67 immunocytology and HPV polymerase chain reaction for the noninvasive analysis of HPV involvement in head and neck cancer.

Maximilian Linxweiler1, Florian Bochen, Silke Wemmert, Cornelia Lerner, Andrea Hasenfus, Rainer Maria Bohle, Basel Al-Kadah, Zoltan Ferenc Takacs, Sigrun Smola, Bernhard Schick.   

Abstract

BACKGROUND: High-risk human papillomavirus (HPV) infection has been identified as a relevant risk for the development of head and neck squamous cell carcinomas (HNSCCs). As HPV status has also gained a role as a prognostic and predictive biomarker for this entity, there is a growing demand for valid HPV testing in HNSCC patients
METHODS: Liquid-based cytological smears from 45 HNSCC and 20 control patients were collected and used for simultaneous immunocytochemical p16(INK4a) /Ki67 staining using a CINtec PLUS kit after the presence of tumor cells was verified in a Papanicolaou-stained slide. The same cytological suspension was used for the detection of HPV DNA by specific polymerase chain reaction (PCR).
RESULTS: Tumor cells were detected in the swab material of 44 HNSCC patients corresponding to a sensitivity of 98% (44 of 45). PCR analysis revealed the presence of HPV DNA in the cytological suspension of 13 patients (13 of 65, 20%) with simultaneous p16(INK4a) /Ki67 expression by the tumor cells in 11 of these HPV DNA-positive samples (11 of 13, 85%) - a staining pattern that is strongly associated with a carcinogenic HPV infection.
CONCLUSIONS: A simultaneous immunocytochemical detection of p16(INK4a) and Ki67 can reliably be performed on liquid-based cytological smears from HNSCC patients using a CINtec PLUS kit. In addition, the same cytological material can be used for the detection of HPV DNA by specific PCR. The combined results of both techniques enable better discrimination between latent and carcinogenic HPV infections as well as HPV-negative cases and thus can provide information on the prognosis of HNSCC patients and facilitate therapeutic decisions.
© 2014 American Cancer Society.

Entities:  

Keywords:  head and neck squamous cell carcinoma (HNSCC); human papillomavirus (HPV); liquid-based cytology; p16INK4a/Ki67 dual stain; prognostic and predictive biomarkers

Mesh:

Substances:

Year:  2014        PMID: 25557267     DOI: 10.1002/cncy.21512

Source DB:  PubMed          Journal:  Cancer Cytopathol        ISSN: 1934-662X            Impact factor:   5.284


  11 in total

1.  Roles of Ki-67 and p16 as biomarkers for unknown primary head and neck squamous cell carcinoma.

Authors:  Toshiya Maebayashi; Naoya Ishibashi; Takuya Aizawa; Masakuni Sakaguchi; Tsutomu Saito; Jiro Kawamori; Yoshiaki Tanaka; Yukari Hirotani; Taku Homma
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-02-12       Impact factor: 2.503

2.  Carcinoma of the urethra.

Authors:  Miao Zhang; Adebowale J Adeniran; Raghunandan Vikram; Pheroze Tamboli; Curtis Pettaway; Jolanta Bondaruk; Jinsong Liu; Keith Baggerly; Bogdan Czerniak
Journal:  Hum Pathol       Date:  2017-08-18       Impact factor: 3.466

3.  Combinational chromosomal aneuploidies and HPV status for prediction of head and neck squamous cell carcinoma prognosis in biopsies and cytological preparations.

Authors:  Silke Wemmert; Maximilian Linxweiler; Cornelia Lerner; Florian Bochen; Philipp Kulas; Johannes Linxweiler; Sigrun Smola; Steffi Urbschat; Stefan Wagenpfeil; Bernhard Schick
Journal:  J Cancer Res Clin Oncol       Date:  2018-03-20       Impact factor: 4.553

4.  IDO1 is highly expressed in macrophages of patients in advanced tumour stages of oral squamous cell carcinoma.

Authors:  Ann-Kristin Struckmeier; Anne Radermacher; Michael Fehrenz; Tamara Bellin; Dalia Alansary; Philipp Wartenberg; Ulrich Boehm; Mathias Wagner; Anja Scheller; Jochen Hess; Julius Moratin; Christian Freudlsperger; Jürgen Hoffmann; Lorenz Thurner; Klaus Roemer; Kolja Freier; Dominik Horn
Journal:  J Cancer Res Clin Oncol       Date:  2022-08-13       Impact factor: 4.322

Review 5.  Current and future techniques for human papilloma virus (HPV) testing in oropharyngeal squamous cell carcinoma.

Authors:  Ali Qureishi; Thomas Mawby; Lisa Fraser; Ketan A Shah; Henrik Møller; Stuart Winter
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-03-11       Impact factor: 2.503

6.  RIPK3 expression in cervical cancer cells is required for PolyIC-induced necroptosis, IL-1α release, and efficient paracrine dendritic cell activation.

Authors:  Susanne V Schmidt; Stefanie Seibert; Barbara Walch-Rückheim; Benjamin Vicinus; Eva-Maria Kamionka; Jennifer Pahne-Zeppenfeld; Erich-Franz Solomayer; Yoo-Jin Kim; Rainer M Bohle; Sigrun Smola
Journal:  Oncotarget       Date:  2015-04-20

Review 7.  Recent Progress in Therapeutic Treatments and Screening Strategies for the Prevention and Treatment of HPV-Associated Head and Neck Cancer.

Authors:  Sonia N Whang; Maria Filippova; Penelope Duerksen-Hughes
Journal:  Viruses       Date:  2015-09-17       Impact factor: 5.048

8.  Effect of 3q oncogenes SEC62 and SOX2 on lymphatic metastasis and clinical outcome of head and neck squamous cell carcinomas.

Authors:  Florian Bochen; Hana Adisurya; Silke Wemmert; Cornelia Lerner; Markus Greiner; Richard Zimmermann; Andrea Hasenfus; Mathias Wagner; Sigrun Smola; Thorsten Pfuhl; Alessandro Bozzato; Basel Al Kadah; Bernhard Schick; Maximilian Linxweiler
Journal:  Oncotarget       Date:  2017-01-17

9.  Oral lichen planus and malignant transformation: The role of p16, Ki-67, Bub-3 and SOX4 in assessing precancerous potential.

Authors:  Eduardo Augusto Rosa; Aura Maria Hurtado-Puerto; Denise Pinheiro Falcão; Aline Patricia Brietzke; Luiz Eduardo De Almeida Prado Franceschi; Florlorêncio Figueiredo Cavalcanti Neto; Valdenize Tiziane; Fabiana Pirani Carneiro; Evelyn Mikaela Kogawa; Heitor Moreno; Rivadávio Fernandes Batista Amorim
Journal:  Exp Ther Med       Date:  2018-03-20       Impact factor: 2.447

10.  HPV Status as Prognostic Biomarker in Head and Neck Cancer-Which Method Fits the Best for Outcome Prediction?

Authors:  Jan Philipp Kühn; Wendelin Schmid; Sandrina Körner; Florian Bochen; Silke Wemmert; Hugo Rimbach; Sigrun Smola; Julia Caroline Radosa; Mathias Wagner; Luc G T Morris; Victoria Bozzato; Alessandro Bozzato; Bernhard Schick; Maximilian Linxweiler
Journal:  Cancers (Basel)       Date:  2021-09-21       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.